| Ms Ruth Ann Quist Jr, | |
|
205 Sunnyview Ln, Kalispell, MT 59901-3120 | |
| (406) 751-4189 | |
| (406) 751-4527 |
| Full Name | Ms Ruth Ann Quist Jr |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Occupational Health |
| Location | 205 Sunnyview Ln, Kalispell, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245356443 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WX0106X | Registered Nurse - Occupational Health | RN17785 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Ruth Ann Quist Jr, 5 Wild Grape Ct, Kalispell, MT 59901-8329 Ph: (406) 756-0336 | Ms Ruth Ann Quist Jr, 205 Sunnyview Ln, Kalispell, MT 59901-3120 Ph: (406) 751-4189 |
News Archive
Researchers have identified risk factors that may help clinicians identify bipolar disorder patients who are at increased risk for substance use disorders.
Up to 5 million deaths a year could be averted if the global population was more active. At a time when many people are home bound due to COVID-19, new WHO Guidelines on physical activity and sedentary behavior, launched today, emphasize that everyone, of all ages and abilities, can be physically active and that every type of movement counts.
November is Chronic Obstructive Pulmonary Disease (COPD) Awareness Month. COPD, also known as emphysema, is the third leading cause of death in the United States, only behind heart disease and cancer. Right now, the only studied interventions that prolong life for patients with severe COPD are supplemental oxygen in people with low oxygen levels and lung volume reduction surgery (LVRS) in appropriately selected individuals.
PARI Pharma has enrolled the first patient in its Phase 2b clinical trial studying inhaled liposomal cyclosporine A (L-CsA) delivered via a customized Investigational eFlow Nebulizer System. The multinational study is investigating the safety and efficacy of PARI's L-CsA formulation. In previous clinical trials, reactions from physicians and lung transplant recipients to PARI's drug-device combination were encouraging.
› Verified 8 days ago
Ms. Teri Grace Lorence, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 205 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-751-4189 Fax: 406-751-4527 | |
Mrs. Jillian Marie Boll, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1035 1st Ave W, Kalispell, MT 59901 Phone: 406-751-8110 | |
Rachel Marie Brewer, APRN Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 160 Heritage Way Ste 202, Kalispell, MT 59901 Phone: 406-752-8433 | |
Ms. Linda Kay Gunderson, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 205 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-751-4189 Fax: 406-751-4527 | |
Ms. Mary Elizabeth Hyle-worbets, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 795 Sunset Blvd Ste F, Kalispell, MT 59901 Phone: 406-260-4181 Fax: 406-260-4183 | |
Sonya Harder Milheim, PMHNP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 2282 Us Highway 93 S, Kalispell, MT 59901 Phone: 406-756-8721 Fax: 406-257-1353 |